$LLY·8-K

ELI LILLY & Co · Apr 30, 7:03 AM ET

Compare

ELI LILLY & Co 8-K

Research Summary

AI-generated summary

Updated

Eli Lilly Files 8-K Reporting Results; Press Release April 30, 2026

What Happened

  • Eli Lilly and Company (LLY) filed a Form 8-K on April 30, 2026 under Item 2.02 to report results of operations and financial condition. The filing furnishes a press release dated April 30, 2026 (Exhibit 99.1) that communicates the company’s financial results and related information. The cover page interactive data file is provided as Exhibit 104. The report is signed by Donald A. Zakrowski, Senior Vice President, Finance, and Chief Accounting Officer.

Key Details

  • Item reported: 2.02 — Results of Operations and Financial Condition (earnings/quarterly results disclosure).
  • Exhibit 99.1: Press release of Eli Lilly and Company, dated April 30, 2026 (contains the detailed financial announcement).
  • Exhibit 104: Inline XBRL cover page interactive data file included.
  • Report signed and dated April 30, 2026 by Donald A. Zakrowski (Senior VP, Finance & CAO).

Why It Matters

  • This 8-K is the company’s official disclosure that it has released material financial results (earnings/quarterly results). Retail investors should review the attached press release (Exhibit 99.1) and any accompanying financial statements or earnings metrics to assess revenue, profitability, guidance, or other changes that could affect LLY’s stock. The 8-K indicates where to find the formal, SEC-filed summary of those results.

Loading document...